Globally a lot more than 100 million people will end up being experiencing Alzheimers disease.

Ron Brookmeyer, a professor in Biostatistics and chair of the Get better at of Public Health System at the Bloomberg School of Public Wellness, says a worldwide epidemic of Alzheimer’s disease is looming. Dr. Brookmeyer predicts that by 2050, 1 in 85 people worldwide could have Alzheimer’s disease. The researchers say the largest upsurge in the prevalence of Alzheimer’s will happen in Asia, where 48 % of the world’s Alzheimer’s cases currently reside; the true number of instances is likely to grow in Asia from 12.65 million in 2006 to 62.85 million in 2050 when 59 % of the world’s Alzheimer’s cases will reside in Asia.IL-33 is the newest member of the IL-1 family of cytokines, which are specific molecules involved in various disease processes, such as for example inflammation, autoimmunity, and malignancy. Cytokines are produced by many types of cells and deliver indicators that allow cells to communicate with one another. ‘We are grateful to the DeGregorio Family Foundation for having chosen to support our project this season and for bringing focus on higher GI malignancies,’ said Theresa Pizarro, PhD, associate professor of Medication and Pathology, Case Western Reserve University College of Medication, and the study's principal investigator. ‘Utilizing a multi-disciplinary strategy, we are hopeful that this research will allow us to study novel pathways which will uncover the potential sequence of occasions that occur from inflammation in the belly to gastric cancer, and to generate more targeted and particular treatment modalities because of this devastating disease, for which there is absolutely no cure currently.